SCRI at Mary Crowley

Mary Crowley Cancer Research joined Sarah Cannon Research Institute (SCRI) in January 2025 under the unified banner of SCRI at Mary Crowley. Patients receive compassionate, personalized care - now with even greater access to cutting-edge therapies including an expanded clinical trial menu, strengthened research capabilities for on-site study operations and access to a personalized medicine platform, Genospace, which transforms patient data into actionable insights for treatment.

SCRI at Mary Crowley is supported by locally trusted and globally recognized Texas Oncology physicians. Together, we are making a greater impact in communities across North Texas.

SCRI at Mary Crowley offers trials in a broad list of cancer types. Please call (972) 566-3000 for more information. Learn more about SCRI at Mary Crowley through the testimonials of our patients, Mary and Bill.